Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,330 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Trabectedin is a promising antitumour agent for synovial sarcoma.
Yasui H, Imura Y, Outani H, Hamada K, Nakai T, Yamada S, Takenaka S, Sasagawa S, Araki N, Itoh K, Myoui A, Yoshikawa H, Naka N. Yasui H, et al. J Chemother. 2016 Oct;28(5):417-24. doi: 10.1080/1120009X.2015.1133013. Epub 2016 Jan 29. J Chemother. 2016. PMID: 27077926
E10A, an adenovirus-carrying endostatin gene, dramatically increased the tumor drug concentration of metronomic chemotherapy with low-dose cisplatin in a xenograft mouse model for head and neck squamous-cell carcinoma.
Adhim Z, Lin X, Huang W, Morishita N, Nakamura T, Yasui H, Otsuki N, Shigemura K, Fujisawa M, Nibu K, Shirakawa T. Adhim Z, et al. Among authors: yasui h. Cancer Gene Ther. 2012 Feb;19(2):144-52. doi: 10.1038/cgt.2011.79. Epub 2011 Nov 25. Cancer Gene Ther. 2012. PMID: 22116375
Prevalence and clinical features of progressive pulmonary fibrosis in patients with unclassifiable idiopathic interstitial pneumonia: A post hoc analysis of prospective multicenter registry.
Kono M, Enomoto N, Inoue Y, Yasui H, Karayama M, Suzuki Y, Hozumi H, Furuhashi K, Toyoshima M, Imokawa S, Fujii M, Akamatsu T, Koshimizu N, Yokomura K, Matsuda H, Kaida Y, Nakamura Y, Shirai M, Masuda M, Fujisawa T, Inui N, Sugiura H, Sumikawa H, Kitani M, Tabata K, Hashimoto D, Ogawa N, Suda T. Kono M, et al. Among authors: yasui h. Respir Investig. 2025 Jan 31;63(2):216-223. doi: 10.1016/j.resinv.2025.01.007. Online ahead of print. Respir Investig. 2025. PMID: 39892159
A phase two trial evaluating FOLFIRI plus aflibercept after failure of FOLFOXIRI plus bevacizumab in patients with unresectable metastatic colorectal cancer.
Ando K, Satake H, Shimokawa M, Yasui H, Negoro Y, Kinjo T, Kizaki J, Baba K, Orita H, Hirata K, Sakamoto S, Makiyama A, Saeki H, Tsuji A, Baba H, Oki E. Ando K, et al. Among authors: yasui h. Int J Clin Oncol. 2025 Feb 1. doi: 10.1007/s10147-025-02701-9. Online ahead of print. Int J Clin Oncol. 2025. PMID: 39891883
1,330 results